69
Views
1
CrossRef citations to date
0
Altmetric
Basic Research

Monoclonal glomerulopathy with features of cryoglobulinemic glomerulopathy in murine multiple myeloma model

, &
Pages 387-394 | Received 25 Sep 2020, Accepted 20 Oct 2020, Published online: 01 Nov 2020
 

ABSTRACT

In vivo and animal models of monoclonal light chain-associated renal diseases are limited. The Vk*MYC transgenic model with multiple myeloma in 50–70 weeks old mice with renal involvement has been reported before, but detailed renal pathologic changes have not been well documented. This study fully investigated pathologic changes in the kidneys of Vk*MYC transgenic model using light microscopy, immunofluorescence stains for kappa and lambda light chains, and electron microscopy. Compared to the kidneys of wild-type mice, the kidneys of transgenic mice showed either mesangial segmental expansion, some with associated hypercellularity, and/or thrombotic obstruction of glomerular capillaries. The glomeruli revealed stronger lambda staining than kappa light chain staining. Six out of 12 kidneys from transgenic mice showed abundant electron-dense deposits when examined ultrastructurally. The deposits were located in glomerular capillary lumina in three cases. Large luminal and subendothelial deposits were characterized by randomly disposed microtubular structures measuring up to 16 nm in diameter, with overall features most consistent with cryoglobulins. In summary, about 50% of kidneys from the Vk*MYC mice with myeloma had features most consistent with monoclonal cryoglobulinemic glomerulopathy.

Acknowledgments

Authors thank Ms. Karen L. Lewinski for her excellent technical assistance. The authors also thank Dr. Leif Bergsagel for his providing the Vk*MYC transgenic mice, and thank Dr. Oalf Kroneman for his critical review of the manuscript. BL is supported by the National Institutes of Health (NIH) R01CA193939 and U01AI125859.

Additional information

Funding

This work was supported by the NIH [National Institutes of Health (NIH) NIH R01CA193939 and U01AI125859].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.